Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo

Summary

There is an unsatisfied medical need for a first-line treatment of localized uncomplicated proliferating Infantile Hemangioma with a good benefit/risk profile. Pierre Fabre Dermatologie has developed a new formulation of propranolol (V0400 GL 01A) which is a topical gel adapted to paediatric use. The objective of this study is to evaluate topical propranolol efficacy and safety in the management of localized hemangioma.

Timeline

Start

2012-01

Primary completion

2013-05

Completion

2013-05

Drugs

Indications